Suppr超能文献

KIF13B 通过高尔基体到质膜的 VEGFR2 运输来调节血管生成。

KIF13B regulates angiogenesis through Golgi to plasma membrane trafficking of VEGFR2.

机构信息

Department of Pharmacology, University of Illinois College of Medicine, Chicago, IL 60612, USA Center of Lung and Vascular Biology, University of Illinois College of Medicine, Chicago, IL 60612, USA.

Department of Pharmacology, University of Illinois College of Medicine, Chicago, IL 60612, USA.

出版信息

J Cell Sci. 2014 Oct 15;127(Pt 20):4518-30. doi: 10.1242/jcs.156109. Epub 2014 Aug 15.

Abstract

Although the trafficking of newly synthesized VEGFR2 to the plasma membrane is a key determinant of angiogenesis, the molecular mechanisms of Golgi to plasma membrane trafficking are unknown. Here, we have identified a key role of the kinesin family plus-end molecular motor KIF13B in delivering VEGFR2 cargo from the Golgi to the endothelial cell surface. KIF13B is shown to interact directly with VEGFR2 on microtubules. We also observed that overexpression of truncated versions of KIF13B containing the binding domains that interact with VEGFR2 inhibited VEGF-induced capillary tube formation. KIF13B depletion prevented VEGF-mediated endothelial migration, capillary tube formation and neo-vascularization in mice. Impairment in trafficking induced by knockdown of KIF13B shunted VEGFR2 towards the lysosomal degradation pathway. Thus, KIF13B is an essential molecular motor required for the trafficking of VEGFR2 from the Golgi, and its delivery to the endothelial cell surface mediates angiogenesis.

摘要

尽管新合成的 VEGFR2 向质膜的转运是血管生成的关键决定因素,但高尔基体到质膜转运的分子机制尚不清楚。在这里,我们发现驱动蛋白家族的正极分子马达 KIF13B 在将 VEGFR2 货物从高尔基体递送到内皮细胞表面方面起着关键作用。结果表明,KIF13B 直接与微管上的 VEGFR2 相互作用。我们还观察到,过表达包含与 VEGFR2 相互作用的结合结构域的截断形式的 KIF13B 抑制了 VEGF 诱导的毛细血管管形成。KIF13B 耗竭可防止 VEGF 介导的内皮细胞迁移、毛细血管管形成和新血管生成。通过敲低 KIF13B 引起的转运受损会将 VEGFR2 转向溶酶体降解途径。因此,KIF13B 是一种从高尔基体运输 VEGFR2 所必需的分子马达,其向内皮细胞表面的输送介导了血管生成。

相似文献

1
KIF13B regulates angiogenesis through Golgi to plasma membrane trafficking of VEGFR2.
J Cell Sci. 2014 Oct 15;127(Pt 20):4518-30. doi: 10.1242/jcs.156109. Epub 2014 Aug 15.
3
KIF13B-mediated VEGFR2 trafficking is essential for vascular leakage and metastasis in vivo.
Life Sci Alliance. 2021 Oct 20;5(1). doi: 10.26508/lsa.202101170. Print 2022 Jan.
4
KIF13B mediates VEGFR2 recycling to modulate vascular permeability.
Cell Mol Life Sci. 2023 Mar 16;80(4):91. doi: 10.1007/s00018-023-04752-5.
5
Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6.
Blood. 2011 Jan 27;117(4):1425-35. doi: 10.1182/blood-2010-06-291690. Epub 2010 Nov 9.
6
The myosin motor Myo1c is required for VEGFR2 delivery to the cell surface and for angiogenic signaling.
Am J Physiol Heart Circ Physiol. 2013 Mar 1;304(5):H687-96. doi: 10.1152/ajpheart.00744.2012. Epub 2012 Dec 21.
7
VEGFR2 Trafficking by KIF13B Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration.
Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):5. doi: 10.1167/iovs.62.2.5.
9
Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
Circ Res. 2012 Mar 2;110(5):716-26. doi: 10.1161/CIRCRESAHA.111.256834. Epub 2012 Jan 26.
10
PH-domain-dependent selective transport of p75 by kinesin-3 family motors in non-polarized MDCK cells.
J Cell Sci. 2010 May 15;123(Pt 10):1732-41. doi: 10.1242/jcs.056366. Epub 2010 Apr 27.

引用本文的文献

2
Decoding the Role of Kinesin Superfamily Proteins in Glioma Progression.
J Mol Neurosci. 2025 Jan 23;75(1):10. doi: 10.1007/s12031-025-02308-9.
4
Involvement of kinesins in skeletal dysplasia: a review.
Am J Physiol Cell Physiol. 2024 Aug 1;327(2):C278-C290. doi: 10.1152/ajpcell.00613.2023. Epub 2024 Apr 22.
6
Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions.
Int J Mol Sci. 2023 Aug 18;24(16):12931. doi: 10.3390/ijms241612931.
7
Control of motor landing and processivity by the CAP-Gly domain in the KIF13B tail.
Nat Commun. 2023 Aug 5;14(1):4715. doi: 10.1038/s41467-023-40425-4.
8
Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides.
Cells. 2023 Apr 1;12(7):1071. doi: 10.3390/cells12071071.
9
KIF13B mediates VEGFR2 recycling to modulate vascular permeability.
Cell Mol Life Sci. 2023 Mar 16;80(4):91. doi: 10.1007/s00018-023-04752-5.
10
SENP6-Mediated deSUMOylation of VEGFR2 Enhances Its Cell Membrane Transport in Angiogenesis.
Int J Mol Sci. 2023 Jan 29;24(3):2544. doi: 10.3390/ijms24032544.

本文引用的文献

1
Spatial regulation of VEGF receptor endocytosis in angiogenesis.
Nat Cell Biol. 2013 Mar;15(3):249-60. doi: 10.1038/ncb2679. Epub 2013 Jan 27.
2
VE-cadherin signaling induces EB3 phosphorylation to suppress microtubule growth and assemble adherens junctions.
Mol Cell. 2012 Dec 28;48(6):914-25. doi: 10.1016/j.molcel.2012.10.011. Epub 2012 Nov 15.
4
VEGFR2 translocates to the nucleus to regulate its own transcription.
PLoS One. 2011;6(9):e25668. doi: 10.1371/journal.pone.0025668. Epub 2011 Sep 28.
5
Basic and therapeutic aspects of angiogenesis.
Cell. 2011 Sep 16;146(6):873-87. doi: 10.1016/j.cell.2011.08.039.
7
Molecular control of endothelial cell behaviour during blood vessel morphogenesis.
Nat Rev Mol Cell Biol. 2011 Aug 23;12(9):551-64. doi: 10.1038/nrm3176.
8
plusTipTracker: Quantitative image analysis software for the measurement of microtubule dynamics.
J Struct Biol. 2011 Nov;176(2):168-84. doi: 10.1016/j.jsb.2011.07.009. Epub 2011 Jul 29.
9
VEGF and angiopoietin signaling in tumor angiogenesis and metastasis.
Trends Mol Med. 2011 Jul;17(7):347-62. doi: 10.1016/j.molmed.2011.01.015. Epub 2011 Apr 12.
10
Vascular smooth muscle Notch signals regulate endothelial cell sensitivity to angiogenic stimulation.
J Biol Chem. 2011 Apr 15;286(15):13741-53. doi: 10.1074/jbc.M110.181842. Epub 2011 Feb 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验